SCHEMBL14347828

SCHEMBL14347828

Cc1ccc(C2(CCNCC(=O)N(C)C)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 4/20 0.44
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
NPSR1 Q6W5P4 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
PKM P14618 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTR1A P08908 1/20 0.37
HTR7 P34969 1/20 0.37
HTR6 P50406 1/20 0.37
HTT P42858 2/20 0.36
CYP2D6 P10635 5/20 0.35
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
HSD11B1 P28845 1/20 0.34
LMNA P02545 2/20 0.34
CYP2C19 P33261 1/20 0.34
KCNH2 Q12809 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14347898 0.95 OPRM1 (0.43) OPRM1ALDH1A1MEN1KMT2ANPSR1
SCHEMBL14347861 0.95 OPRM1 (0.43) OPRM1ALDH1A1MEN1KMT2ANPSR1
SCHEMBL8353867 0.83 OPRM1 (0.41) OPRM1ALDH1A1MEN1KMT2ANPSR1
SCHEMBL14347825 0.83 OPRM1 (0.46) OPRM1ALDH1A1MEN1KMT2ANPSR1
SCHEMBL14347826 0.82 OPRM1 (0.45) OPRM1ALDH1A1MEN1KMT2ANPSR1
SCHEMBL8351471 0.81 SMN1; SMN2 (0.42) ALDH1A1MEN1KMT2ANPSR1L3MBTL1
SCHEMBL8353680 0.79 L3MBTL1 (0.46) OPRM1ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL14347886 0.78 OPRM1 (0.44) OPRM1ALDH1A1MEN1KMT2ANPSR1
SCHEMBL8354295 0.78 OPRM1 (0.44) OPRM1ALDH1A1MEN1KMT2ANPSR1
SCHEMBL14347888 0.77 OPRM1 (0.44) OPRM1ALDH1A1MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312214-B2 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-25 US disclosed